BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33679776)

  • 1. Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction
    Han P; Yu T; Hou Y; Zhao Y; Liu Y; Sun Y; Wang H; Xu P; Li G; Sun T; Hu X; Liu X; Li L; Peng J; Zhou H; Hou M
    Front Immunol; 2021; 12():630693. PubMed ID: 33679776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
    Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
    Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia.
    Zhou H; Qiu JH; Wang T; Yu YY; Liu XN; Li X; Wang YW; Hou Y; Li LZ; Liu XG; Hou M; Peng J
    Blood; 2014 Nov; 124(22):3316-9. PubMed ID: 25298039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia.
    Han P; Hou Y; Zhao Y; Liu Y; Yu T; Sun Y; Wang H; Xu P; Li G; Sun T; Hu X; Liu X; Li L; Peng J; Zhou H; Hou M
    Blood; 2021 Aug; 138(8):674-688. PubMed ID: 33876188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
    Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
    Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentages of PD-1
    Wang Y; Pang N; Wang X; Liu Y; Wang X; Wang L; Sun M; Yasen H; Zhao F; Fan W; Guo X; Ding J
    Hum Vaccin Immunother; 2018 Apr; 14(4):832-838. PubMed ID: 29333980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
    Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
    Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia.
    Qiu J; Liu X; Li X; Zhang X; Han P; Zhou H; Shao L; Hou Y; Min Y; Kong Z; Wang Y; Wei Y; Liu X; Ni H; Peng J; Hou M
    Sci Rep; 2016 Jun; 6():27445. PubMed ID: 27321376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
    Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
    Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin modulates CD4
    Zhao Y; Han P; Liu L; Wang X; Xu P; Wang H; Yu T; Sun Y; Li L; Sun T; Liu X; Zhou H; Qiu J; Wang L; Peng J; Xu S; Hou M
    J Cell Mol Med; 2019 Mar; 23(3):1885-1898. PubMed ID: 30609280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis.
    Birtas Atesoglu E; Tarkun P; Demirsoy ET; Geduk A; Mehtap O; Batman A; Kaya F; Cekmen MB; Gulbas Z; Hacıhanefioglu A
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):248-51. PubMed ID: 25510412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial ROS-dependent CD4
    Li W; Bai Z; Liu J; Tang Y; Yin C; Jin M; Mu L; Li X
    Int Immunopharmacol; 2023 Sep; 122():110597. PubMed ID: 37413931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.
    Ma L; Simpson E; Li J; Xuan M; Xu M; Baker L; Shi Y; Yougbaré I; Wang X; Zhu G; Chen P; Prud'homme GJ; Lazarus AH; Freedman J; Ni H
    Blood; 2015 Jul; 126(2):247-56. PubMed ID: 26036802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput DNA methylation analysis in ITP confirms NOTCH1 hypermethylation through the Th1 and Th2 cell differentiation pathways.
    Liu SY; Qu HT; Sun RJ; Yuan D; Sui XH; Shan NN
    Int Immunopharmacol; 2022 Oct; 111():109105. PubMed ID: 35930913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
    Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of High ICAM-1 Level for Poor Treatment Response to Low-Dose Decitabine in Adult Corticosteroid Resistant ITP Patients.
    Li C; Li L; Sun M; Sun J; Shao L; Xu M; Hou Y; Peng J; Wang L; Hou M
    Front Immunol; 2021; 12():689663. PubMed ID: 34326842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
    Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
    Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells.
    Lai Q; Wang H; Li A; Xu Y; Tang L; Chen Q; Zhang C; Gao Y; Song J; Du Z
    Oncogene; 2018 Apr; 37(17):2302-2312. PubMed ID: 29422611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.
    Shao X; Xu P; Ji L; Wu B; Zhan Y; Zhuang X; Ou Y; Hua F; Sun L; Li F; Wang X; Chen H; Cheng Y
    Clin Transl Med; 2023 Jul; 13(7):e1344. PubMed ID: 37488670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.